World Class Algorithms
Our autonomous AI research expands the reach of dermatological care beyond the exam room, from skin cancer to inflammatory disease. We are currently recruiting pilot locations and research groups interested in skin diagnostics and management.

* 3DermSpot is for Investigational Use Only
Latest News
3Derm Announces Two FDA Breakthrough Device Designations for Autonomous Skin Cancer AI
DermSpot* is an algorithm that uses artificial intelligence (AI) and highly standardized skin images to autonomously detect melanoma, squamous cell carcinoma, and basal cell carcinoma.
DermSpot is being developed in collaboration with primary care physicians and dermatologists across the country.
Our Focus
We’re committed to using technology to increase access for all patients by focusing on high-impact disease areas and solutions




Autonomous AI
Our research prioritizes safety, efficacy, and equity.

No Automation Without Representation
We stand for technology that works for every skin tone.



Want to get involved?
DermSpot* FAQ
What is DermSpot?
DermSpot is an autonomous AI device under investigation by the FDA and is not currently authorized or available for sale. DermSpot is an algorithm that uses artificial intelligence (AI) and highly standardized skin images to autonomously detect the most common forms of skin cancer. DermSpot is being developed in collaboration with primary care physicians and dermatologists across the country.